ClinicalTrials.gg
CompletedNCT03423277Updated Feb 12, 2026Results posted

Easy Stretch Toolkit: A Pilot Study

An interventional study of Easy Stretch Toolkit in Facial Injuries, sponsored by The University of Texas Medical Branch, Galveston. Completed at 1 site in United States. Open to participants aged 7 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-02-12.

Sponsored by The University of Texas Medical Branch, Galveston · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
7 Years to 80 Years
Sex
All
01

Study summary

To research the use of a novel set of intraoral tools called the Easy Stretch Toolkit for the therapeutic management of facial burns and other facial disorders.

Read the detailed description

In this initial pilot study, we plan to recruit 20 adult or pediatric patients who have sustained facial burns or who have sustained a facial injury resulting in scarring, tightness, limited range of motion of facial skin or musculature, or fibrosis to complete the 8 week treatment. Participants will need to be able to attend a weekly telehealth or in person session with the investigators and complete the entire 8 week prescriptive program. Participants will be outpatient. A facial injury can be any disorder that results in scarring, tightness, limited range of motion of facial skin or musculature or fibrosis. Facial burn injury or facial injury is defined as an injury to the midface or lower half of the face and may be unilateral or bilateral. Participants must be in the chronic phase of recovery. Chronic burns are defined as those burns that are not in the acute healing phase, ie., there are no concerns for injury to new or healing skin or wound dehiscence.

02

Conditions studied

  • Facial Injuries

Browse trials for

03

In context

Facial Injuries

22 studies on the registry are indexed under Facial Injuries; 5 are open to participants now.

This study's enrollment of 8 is below the median of 15 across 13 interventional studies indexed under Facial Injuries.

Browse Facial Injuries studies →

Lead sponsor

The University of Texas Medical Branch, Galveston is the lead sponsor of 257 studies on the registry; 38 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 26 (81%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 7-80
  2. Male or Female Sex
  3. Patients who have sustained a facial burn and are now in the chronic phase, or any patient experiencing facial tightness or limited range of motion due to other problems, including patients s/p radiation to the head and neck, trauma, scarring and scleroderma
  4. Chief complaint(s) of limited mouth opening, difficulty chewing or speaking, decreased range of motion for oral structures, and/or limited facial expressions
  5. Subject or caregiver (parent or guardian, in case of pediatric population) must be able to give
  6. Subject or caregiver (parent or guardian, in case of pediatric population) must be able to perform exercises at home and must be able to record time spent using the devices.
  7. Participants who are undergoing other treatment methods such as use of compression garments, skin grafting, radiation or other facial surgery, etc must suspend all of these treatments for the duration of the 2 month trial.
  8. Internet access including access to FaceTime, Skype or Zoom and email access if electing telehealth option for enrollment

Exclusion criteria

Exclusion criteria:

  1. planned or unplanned surgeries for facial skin grafting around lips or nose or oral commissure release during the upcoming 8 weeks
  2. completion of any massaging or other stretching exercises or programs not specified by the investigators
  3. use of new creams or topical treatments for the duration of enrollment in the study.
  4. acutely burn-injured patients
  5. incarceration, or pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • Experimental
    Easy Stretch Toolkit

    All participants will be using one or more of devices for 60 minutes 2 times per day for the duration of the 8 week trial. Prescriptive instructions for specific intraoral placements will be given based on the participant's deficit areas.

    Device: Easy Stretch Toolkit

Interventions

  • DeviceEasy Stretch Toolkit

    Study the use of novel intraoral tools for management of facial burns and other facial disorders

06

What researchers measure

Primary outcomes

  1. Change in the Facial Range of Motion at Baseline and Week 8

    Facial measurements taken during select facial movements/expressions assessed by software program created at UTMB specifically for this project. The degree of change in facial movements will be assessed with 9 facial postures (face at rest, nose wrinkle, gentle smile, broad smile with lips closed, broad smile with teeth together, voice "eee", voice "ooo", pucker lips and open mouth wide), which will be photographed weekly. Two examples of the facial landmarks to be plotted and measured during each of the above expressions include right pupil to outside of right nare and length of philtrum, with the goal of measuring change over time with use of the Easy Stretch devices. Each of these measurements will produce a length in millimeters. Cumulative average of measurements will be reported per facial posture per participant.

    Time frame: 8 weeks

Secondary outcomes

  1. Change in the Facial Disability Index Scores From Baseline to Week 8

    The Facial Disability Index (FDI) is a validated quality-of-life questionnaire consisting of 10 items, each scored on a 0-5 scale. Five items assess physical function and five items assess social well-being and function. Raw subscale scores are transformed according to standard FDI scoring procedures to yield physical function scores ranging from 0 to 100 and social function scores ranging from 0 to 100. The total Facial Disability Index score is calculated by summing the transformed physical and social subscale scores, resulting in a total score range of 0 to 200. Higher scores indicate better facial function and quality of life, while lower scores indicate greater facial disability.

    Time frame: baseline and week 8

07

Results

Posted Feb 12, 2026

Participant flow

Participant flow — Overall Study
MilestoneEasy Stretch Toolkit
Started8
Completed4
Not completed4

Outcome measures

PrimaryChange in the Facial Range of Motion at Baseline and Week 8

Facial measurements taken during select facial movements/expressions assessed by software program created at UTMB specifically for this project. The degree of change in facial movements will be assessed with 9 facial postures (face at rest, nose wrinkle, gentle smile, broad smile with lips closed, broad smile with teeth together, voice "eee", voice "ooo", pucker lips and open mouth wide), which will be photographed weekly. Two examples of the facial landmarks to be plotted and measured during each of the above expressions include right pupil to outside of right nare and length of philtrum, with the goal of measuring change over time with use of the Easy Stretch devices. Each of these measurements will produce a length in millimeters. Cumulative average of measurements will be reported per facial posture per participant.

Time frame:
8 weeks
Reported as:
Median · mm
Change in the Facial Range of Motion at Baseline and Week 8
mmFacial Measurement Data
At Rest-16.12 (-20.56 to 7.99)
Wrinkle Nose-.08 (-16.77 to 6.43)
Gentle Smile-7.34 (-18.78 to 3.02)
Broad Smile Lips Closed4.47 (-10.89 to 16.47)
Broad Smile Show Teeth-3.77 (-13.55 to 11.30)
Say 'ooo'0.53 (-11.24 to 12.03)
Say 'eee'-1.86 (-6.68 to 12.173)
Pucker-2.97 (-12.66 to 14.84)
Open Your Mouth Wide0.14 (-13.95 to 8.57)
SecondaryChange in the Facial Disability Index Scores From Baseline to Week 8

The Facial Disability Index (FDI) is a validated quality-of-life questionnaire consisting of 10 items, each scored on a 0-5 scale. Five items assess physical function and five items assess social well-being and function. Raw subscale scores are transformed according to standard FDI scoring procedures to yield physical function scores ranging from 0 to 100 and social function scores ranging from 0 to 100. The total Facial Disability Index score is calculated by summing the transformed physical and social subscale scores, resulting in a total score range of 0 to 200. Higher scores indicate better facial function and quality of life, while lower scores indicate greater facial disability.

Time frame:
baseline and week 8
Reported as:
Mean · score on a scale
Change in the Facial Disability Index Scores From Baseline to Week 8
score on a scaleFacial Disability Index Score
baseline129.5 (78 to 170)
8 weeks151.5 (105 to 183)

Adverse events

Collected over 8 weeks for each participant or the duration that they were enrolled in the study. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Easy Stretch Toolkit0/8 (0%)0/8 (0%)0/8 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Easy Stretch Toolkit
<=18 years2
Between 18 and 65 years6
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)Easy Stretch Toolkit
Female2
Male6
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Easy Stretch Toolkit
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American2
White6
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Easy Stretch Toolkit
United States8
08

Study locations

1 site
  • University of Texas Medical Branch
    Galveston, Texas 77555, United States
09

References and documents

Publications

  • Clayton NA, Ward EC, Maitz PK. Orofacial contracture management outcomes following partial thickness facial burns. Burns. 2015 Sep;41(6):1291-7. doi: 10.1016/j.burns.2015.02.015. Epub 2015 Jun 26. PubMed 26120089 ↗
  • Clayton NA, Ward EC, Maitz PK. Intensive swallowing and orofacial contracture rehabilitation after severe burn: A pilot study and literature review. Burns. 2017 Feb;43(1):e7-e17. doi: 10.1016/j.burns.2016.07.006. Epub 2016 Aug 26. PubMed 27575671 ↗
  • Macintyre L, Baird M. Pressure garments for use in the treatment of hypertrophic scars--a review of the problems associated with their use. Burns. 2006 Feb;32(1):10-5. doi: 10.1016/j.burns.2004.06.018. PubMed 16413399 ↗
  • Atiyeh BS, El Khatib AM, Dibo SA. Pressure garment therapy (PGT) of burn scars: evidence-based efficacy. Ann Burns Fire Disasters. 2013 Dec 31;26(4):205-12. PubMed 24799851 ↗
  • Clayton NA, Ellul G, Ward EC, Scott A, Maitz PK. Orofacial Contracture Management: Current Patterns of Clinical Practice in Australian and New Zealand Adult Burn Units. J Burn Care Res. 2017 Jan/Feb;38(1):e204-e211. doi: 10.1097/BCR.0000000000000351. PubMed 27359188 ↗
  • Parry I, Sen S, Palmieri T, Greenhalgh D. Nonsurgical scar management of the face: does early versus late intervention affect outcome? J Burn Care Res. 2013 Sep-Oct;34(5):569-75. doi: 10.1097/BCR.0b013e318278906d. PubMed 23816994 ↗
  • Hadlock TA, Urban LS. Toward a universal, automated facial measurement tool in facial reanimation. Arch Facial Plast Surg. 2012 Jul-Aug;14(4):277-82. doi: 10.1001/archfacial.2012.111. PubMed 22508895 ↗
  • Marur T, Tuna Y, Demirci S. Facial anatomy. Clin Dermatol. 2014 Jan-Feb;32(1):14-23. doi: 10.1016/j.clindermatol.2013.05.022. PubMed 24314374 ↗
  • Jorge JJ Jr, Pialarissi PR, Borges GC, Squella SA, de Gouveia Mde F, Saragiotto JC Jr, Goncalves VR. Objective computerized evaluation of normal patterns of facial muscles contraction. Braz J Otorhinolaryngol. 2012 Apr;78(2):41-51. doi: 10.1590/S1808-86942012000200008. PubMed 22499369 ↗
  • Feng G, Zhuang Y, Gao Z. Measurement and analysis of associated mimic muscle movements. J Otol. 2015 Mar;10(1):39-45. doi: 10.1016/j.joto.2015.06.001. Epub 2015 Aug 1. PubMed 29937780 ↗
  • Coulson SE, Croxson GR, Gilleard WL. Quantification of the three-dimensional displacement of normal facial movement. Ann Otol Rhinol Laryngol. 2000 May;109(5):478-83. doi: 10.1177/000348940010900507. PubMed 10823477 ↗
  • VanSwearingen JM, Brach JS. The Facial Disability Index: reliability and validity of a disability assessment instrument for disorders of the facial neuromuscular system. Phys Ther. 1996 Dec;76(12):1288-98; discussion 1298-300. doi: 10.1093/ptj/76.12.1288. PubMed 8959998 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2019 to primary completion in Nov 2022, 44 months.

Results were first posted in Feb 2026, 3 years 3 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 16, 2018
First posted
Feb 6, 2018
StartActual
Feb 28, 2019
Primary completionActual
Nov 7, 2022
CompletionActual
Nov 7, 2022
Results first posted
Feb 12, 2026
Last update
Feb 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03423277
Responsible party
Sponsor
First posted
Feb 6, 2018
Start date
Feb 28, 2019
Primary completion
Nov 7, 2022
Completion
Nov 7, 2022
Results posted
Feb 12, 2026
Last update
Feb 12, 2026

Study contacts

Lori Arguello
principal investigator · employee of University of Texas Medical Branch
Kathleen Kerr
study director · employee of University of Texas Medical Branch

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion